Not a member? Sign Up

Reasons for Joining

    Address your challenges through knowledge sharing with peers from our global network of specialists.

    Benchmark your business initiatives with the who's who in the field.

    Hear from industry pioneers how to maximize ROI in today's challenging economy.

    And best of all It's FREE!
Sign in using your existing
Pharma IQ account
Username or Email:

Sign Up  |  Already a member? Sign In  |  Visit IQPC.com  
Pharma IQ

Columns

24 column results
   Page  of 3  







  • René Holm Buccal Delivery: Simple Physical Chemical Considerations: Efficient treatments options that are acceptable for both the patients and the physicians are the corner stones in drug development within the pharmaceutical industry. In his new column, 'Drug Delivery', René Holm, Head of Pre-formulation at Lundbeck looks at how Buccal delivery has been explored intensively during the last decade to overcome the disadvantages of oral drug delivery. read more
     September 5,2012 by René Holm   0




  • Deepa Arora Safety Data Exchange Agreements: As more pharma organizations’ collaborate, sharing their expertise, it is important that all parties are in agreement of their role and that a degree of compliance exists. Deepa Arora explains these agreements, which are better known as Safety Data Exchange Agreements. read more
     December 5,2012 by Deepa Arora   0




  • Tye Spillum CDMO Quality Agreements: Reviewing the purpose of the Quality Agreement and looking at what degree the customer will be integrated into the manufacturing process from a Quality perspective. Communication, roles, responsibilities, requirements, expectations, level of control, and the decision making process are a few of the key areas. read more
     March 7,2013 by Tye Spillum   0


  • Tye Spillum Why so many FDA Recalls?: Looking at the FDA website for the recalls over the last few years is shocking & disappointing. Columnist Tye Spillum reflects on the consequences this has on the Pharma market and proposes solutions to prevent so many. read more
     February 21,2013 by Tye Spillum   1





  • Tony Hitchcock Off the shelf bio-processing: There is a risk of missing great opportunities in Disposable Solutions for Biomanufacturing if developments are simply restricted to those solutions which offer short term commercial attractions to the industry. read more
     January 22,2013 by Tony Hitchcock   0


  • Tony Hitchcock Disposable Systems - Where Next?: Single-use systems are increasingly becoming the norm for all but very large scale processes. In his column this month, Tony Hitchcock, Head of Manufacturing Technologies at Cobra Biomanufacturing asks where will technology go in the future or is it just a case of driving down costs and increasing standardisation? read more
     November 28,2012 by Tony Hitchcock   0


  • Tony Hitchcock Making Tomorrow's Medicines: As the industry goes forward, it is clear that companies are looking to replenish and expand product pipelines and are relying on biotech products to achieve this.This is a critical challenge which the industry will have to address; not just looking at the use of innovative technologies such as single use systems to reduce development times and costs, but also to produce pioneering products such as stem cell therapies, as well as considering issues such as the relationships between drug development and manufacturing groups. read more
     October 9,2012 by Tony Hitchcock   0

24 column results
   Page  of 3  

Advertisement

Events of Interest
Download Brochure

Please complete the information below to complete your download.

Please note: That all fields marked with an asterisk (*) are required.

First Name *
Last Name *
Job Title *
Company Name *
Email Address *
Telephone *
Country *
Where did you hear about us? *

I would like to receive information about sponsorship and exhibition opportunities

Yes, sign me up for the FREE Pharma IQ e-newsletter, including information on FREE Podcasts, Webinars, event discounts and online learning opportunities.

Top Rated
Most Read